Follow
Tamara Lotan
Tamara Lotan
Professor and Deputy Director for Research, Department of Pathology, Johns Hopkins University
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ...
New England Journal of Medicine 371 (11), 1028-1038, 2014
27862014
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
5542011
Clinical implications of PTEN loss in prostate cancer
T Jamaspishvili, DM Berman, AE Ross, HI Scher, AM De Marzo, JA Squire, ...
Nature Reviews Urology 15 (4), 222-234, 2018
5372018
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation
JI Epstein, MB Amin, H Beltran, TL Lotan, JM Mosquera, VE Reuter, ...
The American journal of surgical pathology 38 (6), 756-767, 2014
5322014
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients
TL Lotan, B Gurel, S Sutcliffe, D Esopi, W Liu, J Xu, JL Hicks, BH Park, ...
Clinical cancer research 17 (20), 6563-6573, 2011
3832011
Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma
HL Tan, A Sood, HA Rahimi, W Wang, N Gupta, J Hicks, S Mosier, ...
Clinical cancer research 20 (4), 890-903, 2014
3422014
Long interspersed element-1 protein expression is a hallmark of many human cancers
N Rodić, R Sharma, R Sharma, J Zampella, L Dai, MS Taylor, RH Hruban, ...
The American journal of pathology 184 (5), 1280-1286, 2014
2892014
The placental gene PEG10 promotes progression of neuroendocrine prostate cancer
S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ...
Cell reports 12 (6), 922-936, 2015
2542015
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation
A Lucioni, GT Bales, TL Lotan, DS McGehee, SP Cook, DE Rapp
BJU international 101 (3), 366-370, 2008
2372008
The role of lineage plasticity in prostate cancer therapy resistance
H Beltran, A Hruszkewycz, HI Scher, J Hildesheim, J Isaacs, EY Yu, ...
Clinical cancer research 25 (23), 6916-6924, 2019
2302019
ERG gene rearrangements are common in prostatic small cell carcinomas
TL Lotan, NS Gupta, W Wang, A Toubaji, MC Haffner, A Chaux, JL Hicks, ...
Modern pathology 24 (6), 820-828, 2011
2292011
A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer
TU Ahearn, A Pettersson, EM Ebot, T Gerke, RE Graff, CL Morais, ...
Journal of the National Cancer Institute 108 (2), djv346, 2016
2002016
The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer
JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ...
Archives of pathology & laboratory medicine 145 (4), 461-493, 2021
1752021
Clinical features and therapeutic outcomes in men with advanced prostate cancer and DNA mismatch repair gene mutations
ES Antonarakis, F Shaukat, PI Velho, H Kaur, E Shenderov, DM Pardoll, ...
European urology 75 (3), 378-382, 2019
1712019
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
TL Lotan, FLF Carvalho, SB Peskoe, JL Hicks, J Good, HL Fedor, ...
Modern Pathology 28 (1), 128-137, 2015
1662015
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD …
ES Antonarakis, P Isaacsson Velho, W Fu, H Wang, N Agarwal, ...
JCO precision oncology 4, 370-381, 2020
1642020
Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls
F Tavora, DA Fajardo, TK Lee, T Lotan, JS Miller, H Miyamoto, JI Epstein
The American journal of surgical pathology 33 (10), 1540-1546, 2009
1492009
MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3. 1 in mouse luminal epithelial cells
T Iwata, D Schultz, J Hicks, GK Hubbard, LN Mutton, TL Lotan, C Bethel, ...
PloS one 5 (2), e9427, 2010
1472010
Comprehensive evaluation of programmed death-ligand 1 expression in primary and metastatic prostate cancer
MC Haffner, G Guner, D Taheri, GJ Netto, DN Palsgrove, Q Zheng, ...
The American journal of pathology 188 (6), 1478-1485, 2018
1462018
MSH2 loss in primary prostate cancer
LB Guedes, ES Antonarakis, MT Schweizer, N Mirkheshti, F Almutairi, ...
Clinical cancer research 23 (22), 6863-6874, 2017
1452017
The system can't perform the operation now. Try again later.
Articles 1–20